POLYMERASE CHAIN-REACTION TO DETECT HEPATITIS-B VIRUS-DNA AND RNA SEQUENCES IN PRIMARY LIVER CANCERS FROM PATIENTS NEGATIVE FOR HEPATITIS-B SURFACE-ANTIGEN

被引:243
作者
PATERLINI, P
GERKEN, G
NAKAJIMA, E
TERRE, S
DERRICO, A
GRIGIONI, W
NALPAS, B
FRANCO, D
WANDS, J
KEW, M
PISI, E
TIOLLAIS, P
BRECHOT, C
机构
[1] INST PASTEUR,HYBRIDOTEST LAB,INSERM,U163,F-75724 PARIS 15,FRANCE
[2] IST CLIN MED,DEPT MED,BOLOGNA,ITALY
[3] DEPT PATHOL & SURG,EVRY,FRANCE
[4] UNIV JOHANNESBURG,DEPT MED,JOHANNESBURG,SOUTH AFRICA
[5] IST CLIN MED,DEPT PATHOL,BOLOGNA,ITALY
[6] HOP LAENNEC,INSERM,U99,UNITE HEPATOL,F-75340 PARIS 07,FRANCE
[7] MASSACHUSETTS GEN HOSP,DEPT GASTROENTEROL,BOSTON,MA 02114
[8] UNIV MAINZ,DEPT MED,W-6500 MAINZ,GERMANY
关键词
D O I
10.1056/NEJM199007123230202
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Methods. The role of hepatitis B virus (HBV) in the course of patients with primary liver cancer who are negative for hepatitis B surface antigen has been debated. We used the polymerase chain reaction to evaluate 28 such patients for the presence of DNA and RNA sequences of the virus; 22 of these patients had associated cirrhosis. The patients were from areas with different prevalences of HBV infection (South Africa, Italy, France, and Japan). Results. Antibodies to the surface and core antigens of HBV were detected in 10 of the 23 patients tested. HBV DNA sequences were detected in 17 of the 28 patients, including 8 of the 10 with HBV antibodies and 6 of 13 without HBV serologic markers. HBV RNA molecules were found in four of five tumors tested. Conclusions. Our investigation indicates that transcriptionally active HBV genomes are present in various geographic areas among patients with liver cancer who are negative for hepatitis B surface antigen. This observation is consistent with an etiologic role for the virus in the development of these tumors. (N Engl J Med 1990; 323:80–5.). © 1990, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:80 / 85
页数:6
相关论文
共 55 条
  • [1] ACKERMAN Z, 1988, VIRAL HEPATITIS LIVE, P783
  • [2] HEPATOCELLULAR-CARCINOMA AND HEPATITIS-B VIRUS
    BEASLEY, RP
    HWANG, LY
    [J]. SEMINARS IN LIVER DISEASE, 1984, 4 (02) : 113 - 121
  • [3] BEASLEY RP, 1982, HEPATOCELLULAR CARCI, P60
  • [4] STRUCTURAL-ANALYSIS OF HEPATITIS-B SURFACE-ANTIGEN BY MONOCLONAL-ANTIBODIES
    BENPORATH, E
    WANDS, JR
    MARCINIAK, RA
    WONG, MA
    HORNSTEIN, L
    RYDER, R
    CANLAS, M
    LINGAO, A
    ISSELBACHER, KJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) : 1338 - 1347
  • [5] BLUM HE, 1988, LIVER, V8, P307
  • [6] STATE OF HEPATITIS-B VIRUS-DNA IN HEPATOCYTES OF PATIENTS WITH HEPATITIS-B SURFACE ANTIGEN-POSITIVE AND ANTIGEN-NEGATIVE LIVER-DISEASES
    BRECHOT, C
    HADCHOUEL, M
    SCOTTO, J
    FONCK, M
    POTET, F
    VYAS, GN
    TIOLLAIS, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (06): : 3906 - 3910
  • [7] HEPATITIS-B VIRUS-DNA IN PATIENTS WITH CHRONIC LIVER-DISEASE AND NEGATIVE TESTS FOR HEPATITIS-B SURFACE-ANTIGEN
    BRECHOT, C
    DEGOS, F
    LUGASSY, C
    THIERS, V
    ZAFRANI, S
    FRANCO, D
    BISMUTH, H
    TREPO, C
    BENHAMOU, JP
    WANDS, J
    ISSELBACHER, K
    TIOLLAIS, P
    BERTHELOT, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (05) : 270 - 276
  • [8] HEPATITIS-B VIRUS (HBV) AND HEPATOCELLULAR-CARCINOMA - HBV DNA STATUS AND ITS IMPLICATIONS
    BRECHOT, C
    [J]. JOURNAL OF HEPATOLOGY, 1987, 4 (02) : 269 - 279
  • [9] BROWN SE, 1984, CLIN EXP IMMUNOL, V55, P355
  • [10] BRUIX J, 1989, LANCET, V2, P1004